A Subject Expert Committee that advises the Drugs Controller General of India has asked Dr. Reddy’s Laboratories to submit data from Phase III clinical trial of Sputnik Light being carried out in Russia.
About
Sputnik Light is a single dose COVID-19 vaccine developed by Russia.
It consists of the first dose of the Sputnik V vaccineSputnik ( same as component-I of Sputnik V), which is based on the Ad26 vector.
It can be stored at a normal refrigerator temperature of 2–8 °C (36–46 °F).
This version would be ideally suited for areas with acute outbreaks, allowing more people to be vaccinated quickly.
It will also be used as a third (booster) dose for those who received Sputnik V at least 6 months earlier.
A phase III clinical trial in Russia also found an efficacy of 79.4%.
